Cystic fibrosis: NHS England strikes deal to offer triple combination treatment

被引：2
|
作者：
Iacobucci, Gareth
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2020年 / 370卷
关键词：
D O I：
10.1136/bmj.m2643
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Scotland strikes deal to offer cystic fibrosis drugs
    Christie, Bryan
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 366 : l5556
  • [2] NHS England and Monitor offer compromise deal to hospitals on payments for procedures
    Limb, Matthew
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [3] NHS England explores funding options for cystic fibrosis drug
    Cohen, Deborah
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 366 : l5600
  • [4] Cystic fibrosis drugs to be available on NHS in England within 30 days
    Kmietowicz, Zosia
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 367 : l6206
  • [5] A new triple combination cystic fibrosis transmembrane regulator modulator
    Perrem, Lucy
    Ratjen, Felix
    [J]. LANCET RESPIRATORY MEDICINE, 2023, 11 (06): : 499 - 500
  • [6] CYSTIC FIBROSIS IMMUNOTHERAPY: USE OF COMBINATION CHEMOTHERAPY FOR TREATMENT OF CYSTIC FIBROSIS LUNG DISEASE
    Randhawa, I.
    Caperton, C.
    Nussbaum, E.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S72 - S72
  • [7] Predicting weight gain in patients with cystic fibrosis on triple combination modulator
    Stewart, Kelly L.
    Szczesniak, Rhonda
    Liou, Theodore G.
    [J]. PEDIATRIC PULMONOLOGY, 2024, 59 (06) : 1724 - 1730
  • [8] Patients With Cystic Fibrosis Have New Triple-Drug Combination
    Voelker, Rebecca
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (21): : 2068 - 2068
  • [9] CFTR modulator triple combination treatment modifies exhaled breath of children with cystic fibrosis within a week
    Bardin, E.
    Hunzinger, N.
    Lamy, E.
    Zhou, B.
    Aubert, M.
    Devillier, P.
    Delyle, S. Grassin
    Sermet-Gaudelus, I.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 68 - 68
  • [10] EFFECT OF NOVEL TRIPLE-COMBINATION ELEXACAFTOR/TEZACAFTOR/IVACAFTOR TREATMENT ON SINONASAL OUTCOMES IN CYSTIC FIBROSIS
    Civantos, A.
    Douglas, J.
    Locke, T.
    Sweis, A.
    Hadjiliadis, D.
    Hong, G.
    Dorgan, D.
    Kohanski, M.
    Palmer, J.
    Adappa, N.
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 : S246 - S246
12345